Inflammatory cytokine expression

**Inflammatory cytokine expression** refers to the biological process by which immune cells such as helper T cells and macrophages produce and release signaling proteins known as pro-inflammatory or inflammatory cytokines. These molecules—including interleukin‑1 (IL‑1), IL‑6, IL‑12, IL‑18, tumor necrosis factor alpha (TNF‑α), interferon gamma (IFNγ), and granulocyte-macrophage colony stimulating factor (GM-CSF)—play central roles in initiating and regulating inflammation during immune responses. Their overproduction is implicated in various diseases including chronic inflammation disorders, cancer progression linked with persistent inflammation, cardiovascular diseases like atherosclerosis, neurodegenerative conditions due to dysregulated signaling in the nervous system, and acute events such as “cytokine storms” during severe infections. Therapies often aim at neutralizing specific inflammatory cytokines or their receptors using monoclonal antibodies rather than targeting “expression” per se. Thus “inflammatory cytokine expression” describes an important physiological phenomenon but does **not** refer to a discrete molecular target suitable for direct drug intervention.[1][2][3] > **Note:** The term "Inflammatory cytokine expression" is *not* itself a canonical therapeutic target but rather describes the activity/state/process involving multiple distinct molecular targets.

Other names

Proinflammatory cytokine expressionExpression of inflammatory cytokinesCytokine upregulation (in context)